BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 5818436)

  • 1. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
    Depisch D; Höfer R; Schatz H
    Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
    [No Abstract]   [Full Text] [Related]  

  • 2. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 3. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.
    Hardisty CA; Fowles A; Munro DS
    J Endocrinol Invest; 1984 Apr; 7(2):151-5. PubMed ID: 6547156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroid acropachy with an abnormally high concentration of long acting thyroid stimulator].
    Momotani N; Suzuki T; Harada S; Nishikawa Y; Ito K
    Horumon To Rinsho; 1972 Aug; 20(8):649-53. PubMed ID: 4678862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
    Studer H
    Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
    From E; Diederichsen H; Heydenreich G; Nielsen OS
    Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
    [No Abstract]   [Full Text] [Related]  

  • 9. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
    Földes J; Gesztesi E; Takács I
    Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 11. [LATS and Graves' disease].
    Gordon A
    Harefuah; 1971 May; 80(10):569-70. PubMed ID: 5171988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and hormonal development of a case of malignant exophthalmus after hypophyseal myskiotomy].
    Stoica T; Arseni C; Constantinescu A; Coculescu M; Balmeş E
    Endocrinologie; 1977; 15(4):283-8. PubMed ID: 579476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

  • 14. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-acting thyroid stimulator].
    Titov VN
    Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
    [No Abstract]   [Full Text] [Related]  

  • 16. Pretibial myxedema.
    Truhan AP
    Am Fam Physician; 1985 May; 31(5):135-8. PubMed ID: 3993510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
    Bonnyns M; Vanhaelst L
    Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
    Winand R
    Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-acting thyroid stimulator (L.A.T.S.) and its place in the physiopathogeny of Basedowian hyperthyroidism].
    Guéritée N
    Rev Fr Endocrinol Clin; 1968; 9(4):351-66. PubMed ID: 5755332
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.